Variant · Snv
TP53 NM_000546.6(TP53):c.673-2A>G
CI-VAR-00079865Explore in graph →NM_000546.6:c.673-2A>GClinVar 458555 rs1555525585
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 458555 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Li-Fraumeni syndrome; Ovarian neoplasm; Hereditary cancer-predisposing syndrome; Li-Fraumeni syndrome 1; Glioma susceptibility 1; Ovarian serous cystadenocarcinoma; Malignant tumor of esophagus; Lung cancer; Familial cancer of breast; Neoplasm; Uterine corpus endometrial carcinoma; Squamous cell lung carcinoma | germline/somatic | 9 | Apr 18, 2025 | clinvar |